Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus
Authors:
Open Access
- 12 August 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Abstract
Few studies were conducted to assess safety and efficacy of continuous antiviral therapy administrated from preconception. In the present study, 136 eligible women with chronic HBV infection were recruited, and assigned to active chronic hepatitis B (CHB) (Group A, B or C) or chronic HBV carrier (Group D). Antiviral therapy was administrated in preconception (Group A), in early (Group B) or late pregnancy (Group C and Group D). Immunoprophylaxis was administrated to all infants. Mothers’ HBV status and ALT were assessed at delivery and 7 months postpartum. Offspring’s HBV status was examined at 7 months old. Group A women showed low HBV DNA level and normal ALT throughout pregnancy. All women at delivery had an HBV DNA level of less than 106 IU/ml, but the proportion of patients with lower HBV DNA level in Group A was higher than any of other three groups (P < 0.05). No differences in obstetrical complications were found among the four groups. None of infants who completed follow-up showed positive HBsAg at age of 7 months. Congenital malformation and infant growth indicators were similar among study cohorts. Continuous antiviral therapy from preconception to entire pregnancy is effective and safe for active CHB mothers and their infants.Keywords
Funding Information
- Clinical Research Project of Guangzhou Medical University (2017[160])
- National Natural Science Foundation of China (81830045)
- National Key Research and Development Program of China (2018YFC1002900)
This publication has 34 references indexed in Scilit:
- Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virusJournal of Clinical Virology, 2013
- Risk factors of HBV intrauterine transmission among HBsAg‐positive pregnant womenJournal of Viral Hepatitis, 2012
- An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B VirusClinical Gastroenterology and Hepatology, 2012
- Effects of Maternal Screening and Universal Immunization to Prevent Mother-to-Infant Transmission of HBVGastroenterology, 2012
- Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothersJournal of Viral Hepatitis, 2011
- The presence and expression of the hepatitis B virus in human oocytes and embryosHuman Reproduction, 2011
- Chronic hepatitis B virus (HBV) infection in pregnancyHepatology International, 2008
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseNew England Journal of Medicine, 2004
- Regulatory T cells mediate maternal tolerance to the fetusNature Immunology, 2004
- Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigenThe Journal of Pediatrics, 1995